In this article, Sue Frankland looks at the global problem of wastage of medications, including causes such as overprescribing and non-adherence. She also presents information from her master’s dissertation on how people understand, and respond to, medication expiration dates
More aggressive secondary prevention of cardiovascular disease now funded
+Educate
In print
Cardiovascular health
More aggressive secondary prevention of cardiovascular disease now funded
Friday 1 April 2022, 12:45 AM
[Image: iStock.com – Rasi Bhadramani]
Consultant cardiologist Chris Ellis discusses the recent funding of rosuvastatin, focusing on its use for secondary prevention of cardiovascular disease
Key points, Rosuvastatin 40mg will lower the LDL cholesterol level by approximately 63 per cent, compared with about 55 per cent with atorvastatin 80mg.
Ezetimi, Education Blue W/ Grey Background W/ Padding
References
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):11188.